NCT06909253Recruiting
Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis
Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis (gMG) Naive to Complement Inhibitors. Prospective, Multicenter, Non-interventional Study (MG-ARCADIA).
Source: ClinicalTrials.gov · Last updated 16 Sept 2026
Brief summary (registry, in English)
The Polish multicentre observational (non-interventional) study aiming to collect data on the management and clinical outcomes of patients with gMG that received ravulizumab.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 27 Mar 2025
- Start date
- 15 May 2025
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- AstraZeneca
- Diseases
- Myasthenia gravis
- NCT number
- NCT06909253
What you commit to
- Study type: Observational
- Planned participants: 50
- From 15 May 2025 to the primary completion date, 31 Dec 2029
- 10 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Those who plan to participate in gMG clinical trial on/after the date of first ravulizumab infusion through NDP.
- Cognitive incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
Who the study is looking for
- Adult (aged ≥18 years) patients with gMG, naive to complement inhibitors, receiving ravulizumab treatment in the frames of NDP in Poland.
- Patients willing to participate in the study and signed Informed Consent Form (ICF).
- Vaccination against N. meningitidis
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (10)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Bydgoszcz | Poland | Recruiting |
| - Coordinator of this site? Confirm its status | Gdansk | Poland | Recruiting |
| - Coordinator of this site? Confirm its status | Katowice | Poland | Recruiting |
| - Coordinator of this site? Confirm its status | Krakow | Poland | Recruiting |
| - Coordinator of this site? Confirm its status | L DZ | Poland | Recruiting |
| - Coordinator of this site? Confirm its status | Lublin | Poland | Recruiting |
| - Coordinator of this site? Confirm its status | Poznan | Poland | Recruiting |
| - Coordinator of this site? Confirm its status | Szczecin | Poland | Recruiting |
| - Coordinator of this site? Confirm its status | Warsaw | Poland | Recruiting |
| - Coordinator of this site? Confirm its status | Wroclaw | Poland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.